Related Experiment Video
Updated: May 6, 2026

In Vivo Quantification of Hip Arthrokinematics during Dynamic Weight-bearing Activities using Dual Fluoroscopy
Published on: July 2, 2021
Musculoskeletal screening: developmental dysplasia of the hip
Insights
Early diagnosis of developmental dysplasia of the hip (DDH) in newborns is crucial. Prompt identification and treatment, often with a Pavlik harness, minimize long-term disability and improve outcomes.
Area of Science:
- Pediatric Orthopedics
- Neonatal Care
- Developmental Biology
Background:
- Developmental dysplasia of the hip (DDH) affects 1 in 100 newborns.
- Delayed diagnosis and treatment of DDH can lead to significant long-term disability.
- Early detection is key to minimizing long-term effects.
Purpose of the Study:
- To outline the importance of early diagnosis and management of DDH.
- To describe screening protocols and treatment interventions for DDH.
- To emphasize the role of specialists in DDH care.
Main Methods:
- Physical examination of all newborns for hip stability.
- Selective ultrasound screening for infants with risk factors (family history, breech presentation, unstable exam).
- Continued hip examination through the first year of life for late-presenting DDH.
Main Results:
- Early diagnosis via physical exam and selective ultrasound screening is feasible.
- Pavlik harness treatment is indicated for infants older than 2 weeks with hip instability.
- Ultrasound screening at 6 weeks is recommended for at-risk infants.
Conclusions:
- Early recognition and intervention for DDH lead to less invasive treatment.
- Timely management minimizes long-term disability associated with DDH.
- Involvement of a DDH specialist ensures optimal patient care and outcomes.
Abstract:
Developmental dysplasia of the hip (DDH) is common because it is present in 1 of 100 newborns. Failure to diagnose DDH and treat in infancy can result in significant long-term disability. Early diagnosis can be accomplished through a quick but careful physical examination of all newborns. Further selective screening by ultrasound is indicated for those children with risk factors for DDH, which include family history, breech presentation, and unstable hip examination at the initial newborn examination. Continued examination of the hip at all routine well-child checkups is mandatory through the first year of life because late presenting DDH may occur. Treatment with a Pavlik harness is not typically instituted in the neonate because many unstable hips stabilize without intervention, but it is indicated in children older than 2 weeks with hip instability. Ultrasound screening for infants with risk factors for DDH is recommended at age 6 weeks. Pavlik harness treatment for children with unstable hips or significant dysplasia on ultrasound is continued until the hips stabilize and show concentric reduction on imaging. With time, diagnosis and treatment evolve to accommodate the growing child. Infants who fail to respond to nonoperative management may require more extensive interventions. At any time when treatment is initiated, a DDH specialist should be involved in the patient's care. If DDH is recognized early, treatment is less invasive, and long-term effects are minimized.
More Related Videos
08:40Author Spotlight: A Novel 3D-Printed Titanium Implant for Minimally Invasive Treatment of Hip Dysplasia in Young Dogs
Published on: April 19, 2024
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019